Skip to main content
Caplight Logo









EXOSOMM

EXOSOMM

Private
HaifaHealthcare & Life Scienceshttps://www.exosomm.com/

Last Round

Grant

Mar 1, 2025

Total Funding Raised

$6.1M

Company Overview

EXOSOMM is a biotechnology and foodtech company that develops nutritional solutions based on natural, milk-derived exosomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

milk exosomesbioactive ingredientsmedical foodnutraceuticalsfunctional nutritioninflammatory bowel diseaseIBDfoodtechbiotechgut healthupcycled ingredientsdairy byproductsnext-gen nutritionsuperfood ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EXOSOMM Comparables

Compare EXOSOMM with similar companies based on industry and business-model similarity.

EXOSOMM comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The Tiny Cargo Company
84%
AlgaHealth
67%
Helaina
64%

EXOSOMM Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2025
SeedJan 1, 2025
GrantMar 1, 2024
AcceleratorMay 3, 2023
Pre SeedMay 3, 2023
Grant
Mar 1, 2023

Key People

Founding team and executive leadership

Rachelle Neumann

Chief Executive Officer

Executive Team

Efrat Dvash Riesenfeld

Chief Technology Officer

Executive Team

Regina Golan Gerstl

CTO

Executive Team

EXOSOMM Investors

Notable investors and investment history

EXOSOMM investors
InvestorRounds
B Capital GroupSeed
Israel Innovation AuthorityPre Seed, Grant
GROWAccelerator
Galil Ofek InnovationPre Seed
Israel Innovation AuthorityPre Seed
HiCenterGrant
AgFunderAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    $1.5M grant from Israel Innovation Authority

  • Jan 1, 2025

    $2M raised with participation from SOSV and Alumni Ventures.

EXOSOMM Filings

Explore SEC and related filing metadata, where available.

EXOSOMM filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EXOSOMM's valuation, stock price, and market status.

Is EXOSOMM a public or private company?

EXOSOMM is a private company.

What is the current stock price of EXOSOMM?

EXOSOMM is a private company with no public stock price. No recent secondary market data is available.

How much is EXOSOMM worth (valuation)?

Valuation information for EXOSOMM is not publicly available.

Can I buy EXOSOMM stock?

EXOSOMM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EXOSOMM's last funding round?

EXOSOMM's most recent funding round was Accelerator on May 3, 2023.

Who are the main investors in EXOSOMM?

Key investors in EXOSOMM include Galil Ofek Innovation.

Will EXOSOMM IPO soon?

No public IPO plans have been announced for EXOSOMM.

How can I track EXOSOMM secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EXOSOMM's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHaifa
Employee Range8
Year Founded2021
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?